Savara Inc Cash and Cash Equivalents, Period Increase (Decrease)
Savara Inc (SVRA) reported Cash and Cash Equivalents, Period Increase (Decrease) of $1.48 million for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-08-09
- Savara Inc cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $1.48M, a 97.08% decline year-over-year.
- Savara Inc cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was $1.00K.
- Savara Inc cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was $2.31M.
- Savara Inc cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$41.32M, a 2943.77% decline year-over-year.
- Savara Inc cash and cash equivalents, period increase (decrease) for fiscal 2017 was $8.75M.
- Savara Inc cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$3.31M, a 182.85% decline from fiscal 2015.
- Savara Inc cash and cash equivalents, period increase (decrease) for fiscal 2015 was $4.00M, a 60.55% decline from fiscal 2014.
- Savara Inc cash and cash equivalents, period increase (decrease) for fiscal 2014 was $10.13M, a 218.36% increase from fiscal 2013.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 181 month | Cash and Cash Equivalents, Period Increase (Decrease) 184 month | Cash and Cash Equivalents, Period Increase (Decrease) 187 month | Cash and Cash Equivalents, Period Increase (Decrease) 190 month | Cash and Cash Equivalents, Period Increase (Decrease) 193 month | Cash and Cash Equivalents, Period Increase (Decrease) 196 month | Cash and Cash Equivalents, Period Increase (Decrease) 199 month | Cash and Cash Equivalents, Period Increase (Decrease) 202 month | Cash and Cash Equivalents, Period Increase (Decrease) 205 month | Cash and Cash Equivalents, Period Increase (Decrease) 208 month | Cash and Cash Equivalents, Period Increase (Decrease) 211 month | Cash and Cash Equivalents, Period Increase (Decrease) 214 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-06-30 | $1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.48M 10-Q · filed 2018-08-09 | $3.79M derived: sum of 3 quarters · filed 2018-08-09 | -$37.53M derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||||||||
| 2018-03-31 | $1.00K 10-Q · filed 2018-05-09 | $2.31M derived: sum of 2 quarters · filed 2018-05-09 | -$39.01M derived: sum of 3 quarters · filed 2018-05-09 | $11.66M derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||||||||
| 2017-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$39.01M derived: sum of 2 quarters · filed 2018-03-14 | $11.66M derived: sum of 3 quarters · filed 2018-08-09 | $8.75M 10-K · filed 2018-03-14 | ||||||||||||||||
| 2017-09-30 | -$41.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $9.35M derived: sum of 2 quarters · filed 2018-08-09 | $6.44M 10-Q · filed 2017-11-08 | $4.30M derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||||||||
| 2017-06-30 | $50.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $47.76M 10-Q · filed 2018-08-09 | $45.62M derived: sum of 3 quarters · filed 2018-08-09 | $47.07M derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||||||||
| 2017-03-31 | -$2.91M 10-Q · filed 2018-05-09 | -$771.00K 10-Q · filed 2017-05-09 | -$5.05M derived: sum of 2 quarters · filed 2018-05-09 | -$3.60M derived: sum of 3 quarters · filed 2018-05-09 | -$6.69M derived: sum of 4 quarters · filed 2018-05-09 | |||||||||||||||
| 2016-12-31 | -$2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$686.00K derived: sum of 2 quarters · filed 2018-03-14 | -$3.78M derived: sum of 3 quarters · filed 2018-03-14 | -$3.31M 10-K · filed 2018-03-14 | -$14.51M 10-K · filed 2017-03-06 | |||||||||||||||
| 2016-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$1.64M derived: sum of 2 quarters · filed 2017-11-08 | -$1.17M 10-Q · filed 2017-11-08 | -$2.53M 10-Q · filed 2016-11-08 | $6.42M derived: sum of 4 quarters · filed 2018-03-14 | |||||||||||||||
| 2016-06-30 | -$3.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$2.62M 10-Q · filed 2017-08-09 | $1.44M 10-Q · filed 2016-08-09 | $4.97M derived: sum of 3 quarters · filed 2018-03-14 | $15.96M derived: sum of 4 quarters · filed 2018-03-14 | |||||||||||||||
| 2016-03-31 | $469.00K 10-Q · filed 2017-05-09 | $8.06M derived: sum of 2 quarters · filed 2018-03-14 | $19.06M derived: sum of 3 quarters · filed 2018-03-14 | $12.34M derived: sum of 4 quarters · filed 2018-03-14 | ||||||||||||||||
| 2015-12-31 | $7.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $18.59M derived: sum of 2 quarters · filed 2018-03-14 | $11.87M derived: sum of 3 quarters · filed 2018-03-14 | $4.00M 10-K · filed 2018-03-14 | -$12.76M 10-K · filed 2016-03-14 | |||||||||||||||
| 2015-09-30 | $10.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $4.27M derived: sum of 2 quarters · filed 2016-11-08 | -$3.60M 10-Q · filed 2016-11-08 | $6.22M derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||||||||
| 2015-06-30 | -$6.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$14.59M 10-Q · filed 2016-08-09 | -$4.77M derived: sum of 3 quarters · filed 2017-03-06 | -$5.15M derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||||||||
| 2015-03-31 | -$7.87M 10-Q · filed 2016-05-06 | $1.95M derived: sum of 2 quarters · filed 2017-03-06 | $1.57M derived: sum of 3 quarters · filed 2017-03-06 | -$1.91M derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||||||||
| 2014-12-31 | $9.83M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $9.44M derived: sum of 2 quarters · filed 2017-03-06 | $5.96M derived: sum of 3 quarters · filed 2017-03-06 | $10.13M 10-K · filed 2017-03-06 | ||||||||||||||||
| 2014-09-30 | -$386.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$3.87M derived: sum of 2 quarters · filed 2015-11-12 | $301.00K 10-Q · filed 2015-11-12 | $300.51K 10-Q · filed 2014-10-31 | -$4.25M derived: sum of 4 quarters · filed 2015-11-12 | |||||||||||||||
| 2014-06-30 | -$3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $687.00K 10-Q · filed 2015-08-12 | $687.36K 10-Q · filed 2014-08-11 | -$3.86M derived: sum of 3 quarters · filed 2015-08-12 | -$18.60M derived: sum of 4 quarters · filed 2015-08-12 | |||||||||||||||
| 2014-03-31 | $4.17M 10-Q · filed 2015-05-11 | $4.17M 10-Q · filed 2014-05-05 | -$382.71K derived: sum of 2 quarters · filed 2015-05-11 | -$15.12M derived: sum of 3 quarters · filed 2015-05-11 | $8.44M derived: sum of 4 quarters · filed 2015-05-11 | $29.85M 10-Q · filed 2014-05-05 | ||||||||||||||
| 2013-12-31 | -$4.55M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24 | -$19.29M derived: sum of 2 quarters · filed 2015-03-24 | $4.27M derived: sum of 3 quarters · filed 2015-03-24 | $3.18M 10-K · filed 2015-03-24 | $3.18M 10-K · filed 2014-03-26 | $25.68M 10-K · filed 2014-03-26 | ||||||||||||||
| 2013-09-30 | -$14.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $8.82M derived: sum of 2 quarters · filed 2014-10-31 | $7.73M 10-Q · filed 2014-10-31 | $4.14M derived: sum of 4 quarters · filed 2014-10-31 | $30.23M 10-Q · filed 2013-11-04 | |||||||||||||||
| 2013-06-30 | $23.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $22.47M 10-Q · filed 2014-08-11 | $18.88M derived: sum of 3 quarters · filed 2014-08-11 | $15.02M derived: sum of 4 quarters · filed 2014-08-11 | $44.97M 10-Q · filed 2013-08-05 | |||||||||||||||
| 2013-03-31 | -$1.09M 10-Q · filed 2014-05-05 | -$4.68M derived: sum of 2 quarters · filed 2014-05-05 | -$8.55M derived: sum of 3 quarters · filed 2014-05-05 | -$13.64M derived: sum of 4 quarters · filed 2014-05-05 | $21.41M 10-Q · filed 2013-05-15 | |||||||||||||||
| 2012-12-31 | -$3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | -$7.46M derived: sum of 2 quarters · filed 2014-03-26 | -$12.55M derived: sum of 3 quarters · filed 2014-03-26 | -$21.07M 10-K · filed 2014-03-26 | $22.50M 10-K · filed 2013-03-19 | |||||||||||||||
| 2012-09-30 | -$3.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | -$8.96M derived: sum of 2 quarters · filed 2013-11-04 | -$17.48M 10-Q · filed 2013-11-04 | -$6.68M derived: sum of 4 quarters · filed 2013-11-04 | $26.09M 10-Q · filed 2012-11-05 | |||||||||||||||
| 2012-06-30 | -$5.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | -$13.61M 10-Q · filed 2013-08-05 | -$2.81M derived: sum of 3 quarters · filed 2013-08-05 | -$12.00M derived: sum of 4 quarters · filed 2013-08-05 | $29.96M 10-Q · filed 2012-08-06 | |||||||||||||||
| 2012-03-31 | -$8.52M 10-Q · filed 2013-05-15 | $2.28M derived: sum of 2 quarters · filed 2013-05-15 | -$6.90M derived: sum of 3 quarters · filed 2013-05-15 | -$11.50M derived: sum of 4 quarters · filed 2013-05-15 | $35.05M 10-Q · filed 2012-05-07 | |||||||||||||||
| 2011-12-31 | $10.80M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-19 | $1.61M derived: sum of 2 quarters · filed 2013-03-19 | -$2.98M derived: sum of 3 quarters · filed 2013-03-19 | $15.59M 10-K · filed 2013-03-19 | $43.57M 10-K · filed 2012-03-08 | |||||||||||||||
| 2011-09-30 | -$9.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | -$13.78M derived: sum of 2 quarters · filed 2012-11-05 | $4.79M 10-Q · filed 2012-11-05 | $3.44M derived: sum of 4 quarters · filed 2012-11-05 | $32.77M 10-Q · filed 2011-11-08 | |||||||||||||||
| 2011-06-30 | -$4.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $13.98M 10-Q · filed 2012-08-06 | $12.62M derived: sum of 3 quarters · filed 2012-08-06 | $10.80M derived: sum of 4 quarters · filed 2012-08-06 | $41.96M 10-Q · filed 2011-08-08 | |||||||||||||||
| 2011-03-31 | $18.57M 10-Q · filed 2012-05-07 | $17.22M derived: sum of 2 quarters · filed 2012-05-07 | $15.39M derived: sum of 3 quarters · filed 2012-05-07 | |||||||||||||||||
| 2010-12-31 | -$1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-08 | -$3.18M derived: sum of 2 quarters · filed 2012-03-08 | $19.31M 10-K · filed 2012-03-08 | |||||||||||||||||
| 2010-09-30 | -$1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $20.66M 10-Q · filed 2011-11-08 | ||||||||||||||||||
| 2010-06-30 | $22.49M 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |